BREAKING NEWS : ASPIRINA MIGLIORA LA NASH IN UN TRIAL AMERICANO RANDOMIZZATO VS PLACEBO! DA “AASLD LIVER MEETING NOVEMBRE 2023”

DIAGNOSTICA PER IMMAGINI, ECOGRAFIA ED ECOENDOSCOPIA, EPATOLOGIA, MEDICINA INTERNA, NEWSLETTER, Senza categoria

  DAILY ASPIRIN THERAPY FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL Robert M. Wilechansky et al. Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic, progressive disease with substantial morbidity and mortality and no approved treatments. Observational studies have linked aspirin use to reduced prevalence and progression of MASLD.…

“GASTRIC OUTLET” OBSTRUCTION: MEGLIO LA GASTROENTEROANASTOMOSI VIA ECOENDO VS LA PROTESI METALLICA DUODENALE ! UN GRANDE TRIAL MULTICENTRICO RANDOMIZZATO. DA” LANCET GASTROENTEROLOGY & HEPATOLOGY”

CHIRURGIA, ECOGRAFIA ED ECOENDOSCOPIA, NUTRIZIONE, ONCOLOGIA, PANCREAS E VIE BILIARI, Senza categoria

Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial Prof Anthony Yuen Bun Teoh et al. Summary Background Endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) is a novel endoscopic method to palliate malignant gastric outlet obstruction. We aimed to assess whether the use of EUS-GE with a…

MALATTIA DI CROHN. LA COMPOSIZIONE DEL MICROBIOMA ANNUNCIA LA COMPARSA DELLA MALATTIA NEI FAMILIARI! DA “GASTROENTEROLOGY! (FREE)

GASTROENTEROLOGIA, IBD, MEDICINA DEI PROBIOTICI, Senza categoria

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives Juan Antonio Raygoza Gara et al. Background & Aims The cause of Crohn’s disease (CD) is unknown, but the current hypothesis is that microbial or environmental factors induce gut inflammation in genetically susceptible individuals, leading to chronic intestinal inflammation. Case-control…

ATTENZIONE ! L’USO DEI BIOLOGICI PER IL CROHN: LE ULTIME LINEE GUIDA DEL GRUPPO IG-IBD! DA” Digestive and Liver Disease ” (FREE)

GASTROENTEROLOGIA, IBD, MEDICINA INTERNA, NEWSLETTER, Senza categoria

Use of biologics for the management of Crohn’s disease: IG-IBD clinical guidelines based on the GRADE methodology Fabio Salvatore Macaluso et al per Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD), Working panel, Review panel A cure for Crohn’s disease (CD), a chronic inflammatory disease of the gastrointestinal tract of unknown etiology, is…

EFFETTO DEL BIFIDOBACTERIUM SULLA GLICEMIA: UNA ATTENTA META-ANALISI NON EVIDENZIA RIDUZIONI NELL’UOMO. DA “Advances in Nutrition” (FREE)

EPATOLOGIA, GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA DEI PROBIOTICI, MEDICINA INTERNA, NEWSLETTER, Senza categoria

The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence Emily P. Van Syoc et al. Abstract Probiotic supplementation is a potential therapeutic for metabolic diseases, including obesity, metabolic syndrome (MetS), and type 2 diabetes (T2D), but most studies deliver multiple species of bacteria in addition to…

PROBIOTICI E PROFILO LIPIDICO NELLA NASH: UNA OTTIMA “UMBRELLA REVIEW” CON META-ANALISI. DA “Systematic Reviews” (FREE)

GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA DEI PROBIOTICI, MEDICINA INTERNA, METODOLOGIA, NEWSLETTER, Senza categoria

Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study Amirhossein Naghipour et al. Abstract Background Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, is closely associated with metabolic conditions such as obesity and diabetes mellitus, which significantly impact human health outcomes. The impaired…